tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LGND Stock Latest News

Ligand management to meet virtually with Oppenheimer
The FlyLigand management to meet virtually with Oppenheimer
11d ago
LGND
Ligand Pharmaceuticals’ Earnings Call Highlights Strong Growth
PremiumCompany Announcements
Ligand Pharmaceuticals’ Earnings Call Highlights Strong Growth
19d ago
LGND
Ligand price target raised to $234 from $185 at RBC Capital
PremiumThe Fly
Ligand price target raised to $234 from $185 at RBC Capital
22d ago
LGND
Ligand price target raised to $220 from $195 at Stifel
PremiumThe Fly
Ligand price target raised to $220 from $195 at Stifel
22d ago
LGND
Ligand price target raised to $220 from $175 at Benchmark
PremiumThe Fly
Ligand price target raised to $220 from $175 at Benchmark
22d ago
LGND
Ligand price target raised to $275 from $250 at Oppenheimer
PremiumThe FlyLigand price target raised to $275 from $250 at Oppenheimer
23d ago
LGND
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
Premium
The Fly
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
23d ago
BFRI
LGND
Ligand Pharmaceuticals Reports Strong Q3 Results and Raises Guidance
Premium
Company Announcements
Ligand Pharmaceuticals Reports Strong Q3 Results and Raises Guidance
23d ago
LGND
Ligand price target raised to $231 from $206 at H.C. Wainwright
PremiumThe Fly
Ligand price target raised to $231 from $206 at H.C. Wainwright
23d ago
LGND
Ligand reports Q3 adjusted EPS $3.09, consensus $1.89
PremiumThe Fly
Ligand reports Q3 adjusted EPS $3.09, consensus $1.89
24d ago
LGND
Ligand reports Q3 adjusted EPS $3.09, consensus $1.89
PremiumThe Fly
Ligand reports Q3 adjusted EPS $3.09, consensus $1.89
24d ago
LGND
Ligand raises FY25 adjusted EPS view $7.40-$7.65 from $6.70-$7.00
PremiumThe Fly
Ligand raises FY25 adjusted EPS view $7.40-$7.65 from $6.70-$7.00
24d ago
LGND
Is LGND a Buy, Before Earnings?
PremiumPre-EarningsIs LGND a Buy, Before Earnings?
26d ago
LGND
Ligand price target raised to $250 from $190 at Oppenheimer
Premium
The Fly
Ligand price target raised to $250 from $190 at Oppenheimer
27d ago
LGND
PTHS
Ligand partner SQ Innovation receives approval from FDA for Lasix ONYU
Premium
The Fly
Ligand partner SQ Innovation receives approval from FDA for Lasix ONYU
2M ago
LGND
Ligand to pay Arecor up to $11M in AT220 royalty financing agreement
PremiumThe Fly
Ligand to pay Arecor up to $11M in AT220 royalty financing agreement
2M ago
LGND
Ligand Pharma Amends Credit Agreement for Stability
PremiumCompany Announcements
Ligand Pharma Amends Credit Agreement for Stability
2M ago
8K
LGND
Ligand price target raised to $190 from $167 at Oppenheimer
PremiumThe Fly
Ligand price target raised to $190 from $167 at Oppenheimer
3M ago
LGND
Ligand price target raised to $175 from $160 at Benchmark
PremiumThe Fly
Ligand price target raised to $175 from $160 at Benchmark
3M ago
LGND
Ligand Pharma’s Strong Financial Position and Strategic Initiatives Justify Buy Rating
PremiumRatingsLigand Pharma’s Strong Financial Position and Strategic Initiatives Justify Buy Rating
3M ago
LGND
Positive Outlook for Ligand Pharma: FDA Approval and Strategic Expansion Drive Growth Potential
Premium
Ratings
Positive Outlook for Ligand Pharma: FDA Approval and Strategic Expansion Drive Growth Potential
3M ago
LGND
Ligand price target raised to $206 from $157 at H.C. Wainwright
Premium
The Fly
Ligand price target raised to $206 from $157 at H.C. Wainwright
3M ago
LGND
TVTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >